Colombo Fort Land & Building Bilan de santé

Santé financière contrôle des critères 1/6

Colombo Fort Land & Building possède un total de capitaux propres de LKR12.4B et une dette totale de LKR33.4B, ce qui porte son ratio d'endettement à 269.2%. Son actif total et son passif total sont LKR70.8B et de LKR58.4B. L'EBIT de Colombo Fort Land & Building est LKR4.5B ce qui fait que son ratio de couverture des intérêts 1.1. Elle dispose de liquidités et de placements à court terme de LKR3.9B.

Informations clés

269.2%

Ratio d'endettement

LK₨33.45b

Dette

Ratio de couverture des intérêts	1.1x
Argent liquide	LK₨3.90b
Fonds propres	LK₨12.43b
Total du passif	LK₨58.41b
Total des actifs	LK₨70.84b

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de CFLB.N0000 ( LKR33.7B ) ne couvrent pas ses passifs à court terme ( LKR38.4B ).

Passif à long terme: Les actifs à court terme de CFLB.N0000 ( LKR33.7B ) dépassent ses passifs à long terme ( LKR20.1B ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de CFLB.N0000 ( 237.8% ) est considéré comme élevé.

Réduire la dette: Le ratio d'endettement de CFLB.N0000 est passé de 250.9% à 269.2% au cours des 5 dernières années.

Couverture de la dette: Le flux de trésorerie opérationnel de CFLB.N0000 est négatif, par conséquent la dette n'est pas bien couverte.

Couverture des intérêts: Les paiements d'intérêts de CFLB.N0000 sur sa dette ne sont pas bien couverts par l'EBIT ( 1.1 x couverture).

Colombo Fort Land & Building Bilan de santé

Santé financière contrôle des critères 1/6

Informations clés

Mises à jour récentes de la santé financière

Recent updates

Second quarter 2025 earnings released: EPS: LK₨0.78 (vs LK₨0.85 loss in 2Q 2024)

The Colombo Fort Land & Building PLC, Annual General Meeting, Sep 30, 2024

First quarter 2025 earnings released: LK₨0.05 loss per share (vs LK₨0.46 profit in 1Q 2024)

Group MD & Executive Director recently bought LK₨89k worth of stock

New minor risk - Share price stability

Group MD & Executive Director recently bought LK₨102k worth of stock

Full year 2024 earnings released: LK₨0.56 loss per share (vs LK₨9.78 profit in FY 2023)

Group MD & Executive Director recently bought LK₨391k worth of stock

Group MD & Executive Director recently bought LK₨310k worth of stock

Group MD & Executive Director recently bought LK₨456k worth of stock

Group MD & Executive Director recently bought LK₨277k worth of stock

Third quarter 2024 earnings released: LK₨0.95 loss per share (vs LK₨2.03 profit in 3Q 2023)

Second quarter 2024 earnings released: LK₨0.85 loss per share (vs LK₨6.87 profit in 2Q 2023)

Group MD & Executive Director recently sold LK₨4.2m worth of stock

New minor risk - Share price stability

Upcoming dividend of LK₨0.25 per share at 0.8% yield

The Colombo Fort Land & Building PLC Proposes First and Final Dividend

The Colombo Fort Land & Building PLC Proposes First and Final Dividend

The Colombo Fort Land & Building PLC, Annual General Meeting, Sep 27, 2023

First quarter 2024 earnings released: EPS: LK₨0.46 (vs LK₨1.55 in 1Q 2023)

Full year 2023 earnings released: EPS: LK₨12.43 (vs LK₨1.48 loss in FY 2022)

Non-Executive Director recently bought LK₨5.7m worth of stock

Third quarter 2023 earnings released: EPS: LK₨2.03 (vs LK₨1.51 in 3Q 2022)

Investor sentiment improves as stock rises 15%

The Colombo Fort Land & Building plc Announces Demise of Ranjeevan Seevaratnam, Independent Non-Executive Director

Second quarter 2023 earnings released: EPS: LK₨6.87 (vs LK₨0.30 in 2Q 2022)

Less than half of directors are independent

Non-Executive Director recently bought LK₨2.1m worth of stock

Non-Executive Director recently bought LK₨3.5m worth of stock

Independent Non Executive Director recently bought LK₨2.6m worth of stock

Independent Non Executive Director recently bought LK₨1.7m worth of stock

First quarter 2023 earnings released: EPS: LK₨1.55 (vs LK₨0.39 in 1Q 2022)

Full year 2022 earnings released: LK₨1.50 loss per share (vs LK₨2.35 loss in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Group MD & Executive Director recently bought LK₨1.4m worth of stock

Group MD & Executive Director recently bought LK₨1.0m worth of stock

Non-Executive Director recently bought LK₨22m worth of stock

Group MD & Executive Director recently bought LK₨206k worth of stock

Second quarter 2022 earnings released: LK₨0.30 loss per share (vs LK₨0.30 loss in 2Q 2021)

First quarter 2022 earnings released: EPS LK₨0.39 (vs LK₨0.51 loss in 1Q 2021)

Group MD & Executive Director recently bought LK₨148k worth of stock

Third quarter 2021 earnings released: EPS LK₨1.11 (vs LK₨1.85 loss in 3Q 2020)

Group MD & Executive Director recently bought LK₨1.2m worth of stock

New 90-day high: LK₨13.40

Second quarter 2021 earnings released: LK₨0.30 loss per share

Group MD & Executive Director recently sold LK₨711k worth of stock

Non-Executive Chairman recently sold LK₨3.8m worth of stock

New 90-day high: LK₨13.30

First quarter earnings released

Full year earnings released - LK₨8.89 loss per share

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines